Maryland Senate Bill SB212

Maryland 2023 Regular Session

• Introduced: 1/23/23
• Refer: 1/23/23

Caption

Genetic Testing - Prohibitions on Disability, Life, and Long-Term Care Insurance and Educational Materials (Genetic Testing Protection Act of 2023)

Impact

The introduction of SB212 is poised to significantly alter the landscape of insurance regulations in Maryland. By establishing prohibitions on the use of genetic tests in the underwriting process, the bill aims to prevent discrimination against policyholders, ensuring that their genetic background will not affect their ability to secure insurance. This legislative change aligns with ongoing national conversations about the ethical implications of genetic information and its relevance in insurance practices, thereby safeguarding individual rights and health information privacy.

Summary

Senate Bill 212, titled the Genetic Testing Protection Act of 2023, aims to prohibit carriers offering life insurance, long-term care insurance, and disability insurance from making decisions regarding coverage based on whether applicants have requested or undergone genetic testing. The bill seeks to enhance protections for individuals against discrimination based on genetic information, thereby promoting access to insurance products regardless of one's genetic predisposition to certain health conditions. Furthermore, the bill mandates that the Maryland Department of Health update educational materials about genetic testing to inform the public about its impact on insurance coverage and the benefits of such testing.

Contention

Despite its supportive intent, the bill has faced scrutiny regarding potential implications for insurance companies, which argue that it could lead to increased costs and potentially undermine the financial viability of the insurance system. Critics of the bill may express concerns about the balance between protecting individual rights and allowing insurers to assess risks based accurately on available data. Discussions surrounding the bill have highlighted the need for responsible policies that protect both consumers and the business interests of insurance providers. The public debate will likely continue as the bill progresses through the legislative process, especially concerning its expected implementation and potential impacts on the insurance market.